LRMR Reports $115M Offering, $244.5M Cash, Breakthrough Therapy for FA, BLA June 2026, Phase 3 Q2 2026
Larimar Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.51
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS